A Novel Vaccinia Virus with Dual Oncolytic and Anti-angiogenic Therapeutic Effects against Triple-Negative Breast Cancer

PURPOSE: Vascular endothelial growth factor (VEGF) expression is higher in triple-negative breast cancers (TNBC) compared to other subtypes and is reported to predict incidence of distant metastases and shorter overall survival. We investigated the therapeutic impact of a vaccinia virus (VACV) GLV-1...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Breast Cancer Res Treat
Auteurs principaux: Gholami, Sepideh, Marano, Andrew, Chen, Nanhai G., Aguilar, Richard J., Frentzen, Alexa, Chen, Chun-Hao, Lou, Emil, Fujisawa, Sho, Eveno, Clarisse, Belin, Laurence, Zanzonico, Pat, Szalay, Aladar, Fong, Yuman
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5724036/
https://ncbi.nlm.nih.gov/pubmed/25391896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-3180-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires